(Q38121335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Oxygen tension level and human viral infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Frédéric Morinet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Luana Casetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jean-Hugues François

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Claude Capron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

11 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

31-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23850460%20AND%20SRC:MED&resulttype=core&format=json

Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

7 January 2021

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hepatitis B and C virus-related carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Influenza Virus Proliferation in Hypoxic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Glut1-mediated glucose transport regulates HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia-inducible factors and the response to hypoxic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1 and Stimulates the Synthesis of Vascular Endothelial Growth Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

HIF-1alpha expression regulates the bactericidal capacity of phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Oncolytic parvoviruses as cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

7 January 2021

Oncolytic virotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia-inducible factors in physiology and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Low oxygen tension enhances hepatitis C virus replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hypoxia signalling through mTOR and the unfolded protein response in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.018